Treace Medical falls after cutting annual revenue forecast
08/05/2024 11:49
** Medical device maker Treace Medical Concepts' TMCI.O
shares fall 57.3% to $4.75 premarket
** Company expects 2024 revenue between $201 mln and $211
mln, vs previous forecast of $220 mln to $225 mln
** CEO John Treace says revised forecast reflects
competition from knockoffs of its Lapiplasty bunion correction
procedure
** As of last close, stock down 12.8% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Treace Medical Concepts
See all newsTreace Medical Q3 revenue falls but slightly beats expectations
Brief: Treace Medical Q3 EPS USD -0.19
Treace Medical Concepts, Inc. reports results for the quarter ended June 30 - Earnings Summary
Treace Medical Q2 revenue tops estimates on higher surgeon adoption; ups outlook
Treace Medical Concepts, Inc. expected to post a loss of 30 cents a share - Earnings Preview